Cothera Bioscience
Developing cancer therapies for
undruggable targets
Latest News
Cothera Bioscience Announces FDA Fast Track Designation for Clinical Program PC-002
San Francisco, California, October 14, 2024 — Cothera Bioscience, a leading biotech innovator advancing clinical stage therapeutics for previously undruggable oncology targets with high unmet medical needs, is pleased to announce that the U.S. Food and Drug Administration (FDA) has
